Gonzalo Hernández

ORCID: 0000-0002-3048-9607
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ubiquitin and proteasome pathways
  • Erythrocyte Function and Pathophysiology
  • Hemoglobinopathies and Related Disorders
  • RNA modifications and cancer
  • DNA Repair Mechanisms
  • Protease and Inhibitor Mechanisms
  • Protein Tyrosine Phosphatases
  • Circular RNAs in diseases
  • Blood properties and coagulation
  • Salivary Gland Disorders and Functions
  • CRISPR and Genetic Engineering
  • Caveolin-1 and cellular processes
  • Oral microbiology and periodontitis research
  • PARP inhibition in cancer therapy
  • BRCA gene mutations in cancer
  • Oral Health Pathology and Treatment
  • Iron Metabolism and Disorders
  • Trace Elements in Health
  • Endoplasmic Reticulum Stress and Disease
  • Amino Acid Enzymes and Metabolism
  • Neurological and metabolic disorders
  • Blood groups and transfusion
  • Genetic Neurodegenerative Diseases
  • Blood disorders and treatments
  • Prostate Cancer Treatment and Research

Universitat Internacional de Catalunya
2020-2025

Universidad Complutense de Madrid
2024-2025

Hospital de Sant Pau
2022

Centre for Biomedical Network Research on Rare Diseases
2022

CIBBIM-Nanomedicine
2019

Vall d'Hebron Institute of Oncology
2019

Universitat Autònoma de Barcelona
2011-2018

Salivary Lactate Dehydrogenase (sLDH) levels seem to be higher in patients with Oral Squamous Cell Carcinoma (OSCC) and Potentially Malignant Disorders (OPMD) than a control group (CG). Case-control study. Patients OPMD [oral leukoplakia (OL) oral lichen planus (OLP)] OSCC who attended two services Spain were selected. sLDH saliva was measured. Epidemiological, periodontal specific variables related collected. A total of 92 included: 12 OSCC, 51 (17 OL 34 OLP), 29 controls. values the...

10.3389/froh.2024.1525936 article EN cc-by Frontiers in Oral Health 2025-01-07

Lysinuric protein intolerance is a rare autosomal disorder caused by mutations in the Slc7a7 gene that lead to impaired transport of neutral and basic amino acids. The gold standard treatment for lysinuric involves low-protein diet citrulline supplementation. While this approach partially improves cationic acid plasma levels alleviates some symptoms, long-term suggested be detrimental may life-threatening complications characterized wide range hematological immunological abnormalities....

10.1186/s10020-025-01100-0 article EN cc-by Molecular Medicine 2025-01-29

BRCA1 is a tumor suppressor that regulates DNA repair by homologous recombination. Germline mutations in are associated with increased risk of breast and ovarian cancer deficient tumors exquisitely sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors. Therefore, uncovering additional components this pathway extreme importance for further understanding development therapeutic vulnerabilities. Here, we identify EDC4, known component processing-bodies regulator mRNA decapping, as member...

10.1038/s41467-018-03433-3 article EN cc-by Nature Communications 2018-02-28
Griselda Martrat Christopher A. Maxwell Emiko Tominaga Montserrat Porta-de-la-Riva Núria Bonifaci and 95 more Laia Gómez‐Baldó Massimo Bogliolo Conxi Lázaro Ignacio Blanco Joan Brunet Helena Aguilar Juana Fernández‐Rodríguez Sheila Seal Anthony Renwick Nazneen Rahman Julia Kühl Kornelia Neveling Detlev Schindler Marı́a José Ramı́rez María Castellá Gonzalo Hernández Douglas F. Easton Susan Peock Margaret Cook Clare T Oliver Debra Frost Radka Platte D. Gareth Evans Fiona Lalloo Rosalind A. Eeles Louise Izatt Carol Chu Rosemarie Davidson Kai-Ren Ong Jackie Cook Fiona Douglas Shirley Hodgson Carole Brewer Patrick J. Morrison Mary Porteous Paolo Peterlongo Siranoush Manoukian Bernard Peissel Daniela Zaffaroni Gaia Roversi Monica Barile Alessandra Viel Barbara Pasini Laura Ottini Anna Laura Putignano Antonella Savarese Loris Bernard Paolo Radice Sue Healey Amanda B. Spurdle Xiaohong Chen Jonathan Beesley Matti A. Rookus Senno Verhoef Madeleine A Tilanus-Linthorst Maaike P.G. Vreeswijk Christi J. van Asperen Daniëlle Bodmer Margreet G.E.M. Ausems Theo A. van Os Marinus J. Blok Hanne Meijers‐Heijboer Frans B.L. Hogervorst David E. Goldgar Saundra S. Buys Esther M. John Alexander Miron Melissa C. Southey Mary B. Daly Katja Harbst Åke Borg Johanna Rantala Gisela Barbany Hans Ehrencrona Marie Stenmark‐Askmalm Bella Kaufman Yael Laitman Roni Milgrom Eitan Friedman Susan M. Domchek Katherine L. Nathanson Timothy R. Rebbeck Óskar Þór Jóhannsson Fergus J. Couch Xianshu Wang Zachary Fredericksen Daniel Cuadras Vı́ctor Moreno Friederike K Pientka Reinhard Depping Miguel de la Hoya Ana Osório Javier Benı́tez Juan A. Bueren Tuomas Heikkinen

Abstract Introduction Proteins encoded by Fanconi anemia (FA) and/or breast cancer (BrCa) susceptibility genes cooperate in a common DNA damage repair signaling pathway. To gain deeper insight into this pathway and its influence on risk, we searched for novel components through protein physical interaction screens. Methods Protein interactions were screened using the yeast two-hybrid system. Co-affinity purifications endogenous co-immunoprecipitation assays performed to corroborate...

10.1186/bcr2862 article EN cc-by Breast Cancer Research 2011-04-01

ABSTRACT Background Diabetes mellitus (DM) has been associated with salivary disorders such as xerostomia and hyposalivation. The aim of this study was to determine the prevalence these their risk factors in DM patients. Methods patients from two health centers were included. Epidemiological control‐related variables collected. Xerostomia Inventory filled out by unstimulated whole flow Logistic regression tests performed. Results A total 168 included (46.4% men, 53.6% women, mean age 72.54...

10.1111/jop.13583 article EN cc-by-nc-nd Journal of Oral Pathology and Medicine 2024-09-29

Congenital dyserythropoietic anemia type II (CDA II) is an inherited autosomal recessive blood disorder which belongs to the wide group of ineffective erythropoiesis conditions. It characterized by mild severe normocytic anemia, jaundice, and splenomegaly owing hemolytic component. This often leads liver iron overload gallstones. CDA caused biallelic mutations in SEC23B gene. In this study, we report 9 new cases identify 16 pathogenic variants, 6 are novel. The newly reported variants...

10.3390/ijms24129935 article EN International Journal of Molecular Sciences 2023-06-09

Hereditary hemochromatosis (HH) is an iron metabolism disease clinically characterized by excessive deposition in parenchymal organs such as liver, heart, pancreas, and joints. It caused mutations at least five different genes. HFE the most common type of hemochromatosis, while non-HFE related are rare cases. Here, we describe six new patients HH from families. Two families (Family 1 2) have novel nonsense

10.3390/genes12121980 article EN Genes 2021-12-13

Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare disease characterized by high serum ferritin levels, congenital bilateral cataracts, and the absence of tissue iron overload. This disorder produced mutations in responsive element (IRE) located 5′ untranslated regions (UTR) light (FTL) gene. A canonical IRE mRNA structure that interacts with regulatory proteins (IRP1 IRP2) to post-transcriptionally regulate expression related metabolism. Ferritin L H are responsible for storage...

10.3390/ijms22115451 article EN International Journal of Molecular Sciences 2021-05-21

Divalent metal-iron transporter 1 (DMT1) is a mammalian iron encoded by the SLC11A2 gene. DMT1 has vital role in homeostasis mediating uptake intestine and kidneys recovering from recycling endosomes after transferrin endocytosis. Mutations cause an ultra-rare hypochromic microcytic anemia with overload (AHMIO1), which been described eight patients so far. Here, we report two novel cases of this disease. The first proband homozygous for new splicing variant (c.762 + 35A > G), becoming...

10.3390/ijms23084406 article EN International Journal of Molecular Sciences 2022-04-15

BRCA2 is essential for homologous recombination DNA repair. mutations lead to genome instability and increased risk of breast ovarian cancer. Similarly, in BRCA2-interacting proteins are also known modulate sensitivity damage agents established cancer factors. Here we identify the tumor suppressor CDK5RAP3 as a novel helical domain-interacting protein. depletion induced resistance, single-strand annealing upregulation, reduced spontaneous damage-induced genomic instability, suggesting that...

10.3390/cancers14020353 article EN Cancers 2022-01-12

ABSTRACT Friedreich Ataxia (FA) is a cardio-neurodegenerative disease caused by mutations in the frataxin gene, which result low expression. It well-established that deficiency affects iron homeostasis, but tissue-specificity of these alterations poorly understood. In this study, we have analyzed homeostasis FXNI151F mouse model, presents systemic and neurological defects resembling FA patients. Iron overload observed brain from 21-week old mice, both males females, it does not further...

10.1101/2024.07.05.602088 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-07-06

Background: The IRP/IRE post-transcriptional regulatory system controls iron cellular level by modifying the expression of several proteins related to acquisition, mobilization and storage. This regulation is achieved binding IRP1 IRP2 IRE-containing UTRs in iron-deficient conditions. Previously we described complete IRP RNP regulon mice (Sanchez et al 2011 Blood) identifying more than 260 mRNAs that immunoprecipitate with and/or IRP2. Aims: Protein phosphatase 1 inhibitor subunit 1b,...

10.1097/01.hs9.0000968068.53262.5e article EN cc-by-nc-nd HemaSphere 2023-08-01

Abstract Lysinuric Protein Intolerance (LPI) is an inborn error of metabolism resulting from SLC7A7 deficiency that causes diminished plasma concentration cationic amino acids. The clinical picture highly heterogeneous among patients, who commonly present intolerance to protein intake and more severe complications such as hematological abnormalities kidney failure. Although current treatments aim address the metabolic defects LPI, they have been unsatisfactory when treating most symptoms....

10.1101/2021.08.15.456393 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2021-08-16

Topic: 28. Enzymopathies, membranopathies and other anemias Background: We recently reported that RACGAP1 mutations are responsible for Congenital Dyserythropoietic Anemia (CDA) type IIIb, a rare autosomal recessive disease characterized by macrocytic anemia giant multinucleated erythroblasts in the bone marrow. So far, three have been identified causing CDA IIIb humans: Thr220Ala, Leu396Gln Pro432Ser, two latter affecting GAP domain. It was previously described complete abrogation of...

10.1097/01.hs9.0000972784.01629.bb article EN cc-by-nc-nd HemaSphere 2023-08-01

En este articulo se presenta uno de los resultados del proyecto investigacion que tuvo como objetivo identificar manera georreferenciada a nivel direcciones urbanas, patrones eventos delictivos fatales y no partir la informacion almacenada en el Observatorio Delito Municipio Pasto (Colombia) con tecnicas mineria datos. Para analizar un evento delictivo procesarlo geograficamente, construyo geocodificador bajo codigo abierto, urbanas municipio Pasto, permitio georreferenciar cada delictivo....

10.18687/laccei2017.1.1.93 article ES 2017-01-01
Coming Soon ...